Related Experiment Videos
Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients
1Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.
American Journal of Hematology
|September 1, 1996
Abstract:
The use of low molecular weight heparin (LMWH) as prophylaxis for veno-occlusive disease of the liver has been studied in patients undergoing bone marrow transplantation (BMT). The present study analyzes the effect of LMWH on the time course of platelet recovery after BMT. Significantly accelerated platelet recovery in conjunction with lessened requirements of platelet transfusions was observed in the LMWH-treated patients.